It is important to work closely with rare disease patient communities to identify the disease hallmarks that are important to that community, address any gaps and identify the best way to measure and capture those hallmarks.
TORONTO (PRWEB) October 18, 2021
Looking to better assess treatment benefit, drug developers for rare diseases are eager to incorporate remote monitoring solutions to complement the “snapshot” data collected at clinical visits and to collect richer data on how patients function at home. Remote digital endpoints allow for objective data capture in combination with real-time patient feedback and provide a path to more meaningful data and improved patient access to much-needed treatments.
Making this a reality has proven more difficult and time-consuming than hoped, with challenges around validation and interpretation of digital endpoints. It is important to work closely with rare disease patient communities to identify the disease hallmarks that are important to that community, address any gaps and identify the best way to measure and capture those hallmarks.
Register for this webinar to hear the speakers discuss case studies and ongoing efforts to utilizing digital endpoints in pediatric neuromuscular disease and sleep disturbance associated with epilepsy. Ultimately, to realize the full potential of this approach, the selected digital endpoints need to be seamlessly integrated into the wider clinical program. Considerations for successfully implementing this approach on a global scale will be covered.
Join experts from Labcorp Drug Development’s Rare Disease and Pediatric Team, Leone Atkinson, MD, PhD, Executive Medical Director and Louise Kearney, MSc, PMP, Executive Director, along with Aycan Palazoglu, Head of Clinical Trials from Aparito, for the live webinar on Wednesday, November 3, 2021 at 10am EDT (2pm GMT/UK).
For more information, or to register for this event, visit Advancing Meaningful Remote Digital Endpoints for Rare Disease Clinical Trials.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.